Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast

April 2017 | | ID: IFF7696A84CEN
Renub Research

Abstracts

Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast is report published by Renub Research. According to this report, in the Southern European countries, Italy is having the highest seasonal influenza vaccine market share followed by Spain. In terms of children vaccination, Italy & Spain holds more than 80 percent market share whereas, in adult vaccination segments, these two will share more than 90 percent market share by 2022.

This report provides a complete analysis of 4 Southern European Countries (Italy, Malta, Portugal and Spain) Seasonal Influenza Vaccine Market (Child & Adult), Number of Vaccinated Population (Child & Adult) and Forecast till 2022. All the 4 countries in the report have been studied from 2 viewpoints.

1. Seasonal Influenza Vaccine Market in Southern Europe Countries (2011 – 2022)
  Seasonal Influenza Vaccine Market & Forecast
  Children Seasonal Influenza Vaccine Market & Forecast
  Adult Seasonal Influenza Vaccine Market & Forecast
2. Seasonal Influenza Vaccinated Population in Southern Europe Countries (2011 – 2022)
  Seasonal Influenza Vaccinated Population & Forecast
  Children Seasonal Influenza Vaccinated Population & Forecast
  Adult Seasonal Influenza Vaccinated Population & Forecast

Countries studied in the report are as follows

• Italy
• Malta
• Portugal
• Spain

Contents

1. EXECUTIVE SUMMARY

2. SOUTHERN EUROPEAN COUNTRIES SEASONAL INFLUENZA VACCINATED TOTAL POPULATION

2.1 Seasonal Influenza Vaccinated Child Population in Southern European Countries
2.2 Seasonal Influenza Vaccinated Adult Population in Southern European Countries

3. SOUTHERN EUROPEAN COUNTRIES SEASONAL INFLUENZA VACCINE MARKET

3.1 Seasonal Influenza Child Vaccine Market in Southern Europe Countries
3.2 Seasonal Influenza Adult Vaccine Market in Southern Europe Countries

4. SOUTHERN EUROPE COUNTRIES SEASONAL INFLUENZA VACCINE MARKET SHARE

4.1 Southern Europe Countries Seasonal Influenza Vaccine Market Share
4.2 Southern Europe Countries Seasonal Influenza Child Vaccine Market Share
4.3 Southern Europe Countries Seasonal Influenza Adult Vaccine Market Share

5. ITALY

5.1 Italy Seasonal Influenza Vaccinated Total Population
  5.1.1 Italy Seasonal Influenza Vaccinated Child Population
  5.1.2 Italy Seasonal Influenza Vaccinated Adult Population
5.2 Italy Seasonal Influenza Vaccine Market
  5.2.1 Italy Seasonal Influenza Child Vaccine Market
  5.2.2 Italy Seasonal Influenza Adult Vaccine Market

6. MALTA

6.1 Malta Seasonal Influenza Vaccinated Total Population
  6.1.1 Malta Seasonal Influenza Vaccinated Child Population
  6.1.2 Malta Seasonal Influenza Vaccinated Adult Population
6.2 Malta Seasonal Influenza Vaccine Market
  6.2.1 Malta Seasonal Influenza Child Vaccine Market
  6.2.2 Malta Seasonal Influenza Adult Vaccine Market

7. PORTUGAL

7.1 Portugal Seasonal Influenza Vaccinated Total Population
  7.1.1 Portugal Seasonal Influenza Vaccinated Child Population
  7.1.2 Portugal Seasonal Influenza Vaccinated Adult Population
7.2 Portugal Seasonal Influenza Vaccine Market
  7.2.1 Portugal Seasonal Influenza Child Vaccine Market
  7.2.2 Portugal Seasonal Influenza Adult Vaccine Market

8. SPAIN

8.1 Spain Seasonal Influenza Vaccinated Total Population
  8.1.1 Spain Seasonal Influenza Vaccinated Child Population
  8.1.2 Spain Seasonal Influenza Vaccinated Adult Population
8.2 Spain Seasonal Influenza Vaccine Market
  8.2.1 Spain Seasonal Influenza Child Vaccine Market
  8.2.2 Spain Seasonal Influenza Adult Vaccine Market

9. SEASONAL INFLUENZA VACCINE - GROWTH DRIVERS

9.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
9.2 Declining Child Population & Accelerating Ageing Population in Southern European Region
9.3 Rising Healthcare Expenditure Share of the Southern Europe Countries GDP

10. SEASONAL INFLUENZA VACCINE – CHALLENGES

10.1 Regulatory Challenges with New and Novel Influenza Vaccines
10.2 Lack of Healthcare Infrastructure
10.3 Limited Reimbursement and Access to the Vaccines

List Of Figures

LIST OF FIGURES

Figure 2 1: Southern Europe Countries - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 2 2: Southern Europe Countries – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 2 3: Southern Europe Countries - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: Southern Europe Countries – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: Southern Europe Countries - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: Southern Europe Countries – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: Southern Europe Countries - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 3 2: Southern Europe Countries – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 3 3: Southern Europe Countries – Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 3 4: Southern Europe Countries – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 3 5: Southern Europe Countries – Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 3 6: Southern Europe Countries – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 4 1: Southern Europe Countries - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Figure 4 2: Southern Europe Countries – Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Figure 4 3: Southern Europe Countries – Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Figure 4 4: Southern Europe Countries – Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Figure 4 5: Southern Europe Countries – Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Figure 4 6: Southern Europe Countries – Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Figure 5 1: Italy - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 5 2: Italy - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 5 3: Italy - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Italy - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Italy - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Italy - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Italy - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 5 8: Italy - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 5 9: Italy - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 5 10: Italy - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 5 11: Italy - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 5 12: Italy- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 6 1: Malta - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 6 2: Malta – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 6 3: Malta – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Malta – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Malta – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Malta – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Malta - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 8: Malta – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 9: Malta – Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 10: Malta – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 11: Malta - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 12: Malta – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 1: Portugal - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 7 2: Portugal - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 7 3: Portugal - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: Portugal - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: Portugal - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: Portugal - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 7 7: Portugal - Seasonal Influenza Vaccine Market (Million US$), 2011 – 2016
Figure 7 8: Portugal - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 7 9: Portugal - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 7 10: Portugal - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 7 11: Portugal - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 7 12: Portugal - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 8 1: Spain – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 8 2: Spain – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 8 3: Spain – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 8 4: Spain – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 8 5: Spain - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 8 6: Spain – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 8 7: Spain - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 8 8: Spain – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 8 9: Spain –Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 8 10: Spain – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 8 11: Spain - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 8 12: Spain – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 9 1: Vaccine Manufacturers – Influenza Vaccine Production (Million Doses), 2013-2015
Figure 9 2: Southern Europe Countries – Child Population (Thousand), 2010 – 2016
Figure 9 3: Southern Europe Countries – Forecast for Child Population (Thousand), 2017 – 2022
Figure 9 4: Southern Europe Countries – Ageing Population (Thousand), 2010 – 2016
Figure 9 5: Southern Europe Countries – Forecast for Ageing Population (Thousand), 2017 – 2022
Figure 10 1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019

List Of Tables

LIST OF TABLES

Table 9 1: Southern Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 – 2015